GSK2141795,
Uprosertib,
1047634-65-0,
GSK2141795,
UNII-ZXM835LQ5E,
GSK795,
Uprosertib (GSK2141795),
GSK2141795C,
ZXM835LQ5E,
GSK-2141795,
2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-;2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-,
Uprosertib [USAN:INN],
Uprosertib (USAN/INN),
SCHEMBL168584,
Uprosertib, GSK2141795,
GTPL7902,
CHEMBL3137336,
AXTAPYRUEKNRBA-JTQLQIEISA-N,
BCP28204,
EX-A1593,
BDBM50170284,
MFCD28144686,
s7492,
ZINC43197676,
AKOS027323909,
CS-3087,
DB11969,
SB17237,
NCGC00390653-01,
HY-15965,
Uprosertib (GSK-2141795,GSK795),
D10674,
2-Furancarboxamide, N-((1S)-2-amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-,
N-((1S)-1-(Aminomethyl)-2-(3,4-difluorophenyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide,
N-((S)-1-Amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide,
N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide,
N-{(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide,
D01NEC,
A15809,
C000595149,